Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Aclarion, Inc. (ACON : NSDQ)

• Company Description    Aclarion Inc. is a healthcare technology company which leverages Magnetic Resonance Spectroscopy and a proprietary biomarker to optimize clinical treatments. The Company is also researching the application of AI and machine learning platforms to analyze both the raw spectroscopy data and the post-processed signal to evaluate whether AI platforms. Aclarion Inc. is based in SAN MATEO, CA. Number of Employees: 6

• Price / Volume Information    Yesterday's Closing Price: $4.60 Daily Weekly Monthly 20 Day Moving Average: 101,926 shares Shares Outstanding: 0.67 (millions) Market Capitalization: $3.09 (millions) Beta: 1.44 52 Week High: $2,156.33 52 Week Low: $4.32 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -33.76% -33.65% 12 Week -45.43% -46.31% Year To Date 0.00% 0.00%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 8181 Arista Place Suite 100 - Broomfield,Co 80021 USA ph: 833-275-2266 fax: - None http://www.aclarion.com

• General Corporate Information    Officers Brent Ness - President; Chief Executive Officer and Director Jeffrey Thramann - Executive Chairman and Director John Lorbiecki - Chief Financial Officer Stephen Deitsch - Director David Neal - Director Peer Information Aclarion, Inc. (CHCR) Aclarion, Inc. (ESRX) Aclarion, Inc. (MYDP) Aclarion, Inc. (COR) Aclarion, Inc. (GBCS) Aclarion, Inc. (LAXAF) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: Medical Services Sector: Medical CUSIP: 655187409 SIC: 8071 Fiscal Year Fiscal Year End: December Last Reported Quarter: 09/01/25 Next Expected EPS Date: 04/14/26 Share - Related Items Shares Outstanding: 0.67 Most Recent Split Date: 3.00 (0.04:1) Beta: 1.44 Market Capitalization: $3.09 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-2.79 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-13.71 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 04/14/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 0.21 Price/Cash Flow: - Price / Sales: 45.94 EPS Growth vs. Year Ago Period: 99.78% vs. Previous Quarter: -6.55% Sales Growth vs. Year Ago Period: 35.71% vs. Previous Quarter: 0.00% ROE 12/31/25 - - 09/30/25 - -67.53 06/30/25 - -83.63 ROA 12/31/25 - - 09/30/25 - -63.01 06/30/25 - -76.55 Current Ratio 12/31/25 - - 09/30/25 - 17.01 06/30/25 - 23.83 Quick Ratio 12/31/25 - - 09/30/25 - 17.01 06/30/25 - 23.83 Operating Margin 12/31/25 - - 09/30/25 - -10,908.50 06/30/25 - -11,238.59 Net Margin 12/31/25 - - 09/30/25 - -10,908.50 06/30/25 - -11,238.59 Pre-Tax Margin 12/31/25 - - 09/30/25 - -10,908.50 06/30/25 - -11,238.59 Book Value 12/31/25 - - 09/30/25 - 21.47 06/30/25 - 24.37 Inventory Turnover 12/31/25 - - 09/30/25 - - 06/30/25 - - Debt-to-Equity 12/31/25 - - 09/30/25 - 0.00 06/30/25 - 0.00 Debt-to-Capital 12/31/25 - - 09/30/25 - 0.00 06/30/25 - 0.00

Powered by Zacks Investment Research ©